CANCARD
Enteric-coated tablet 30s 100s
registration number
48/2.7/0609
What CANCARD is and what it is used for
CANCARD is indicated in adults for indications related to inhibition of platelet aggregation:
• To reduce the risk of myocardial infarction in patients with unstable angina or in patients who have had a previous myocardial infarction,
• to reduce the risk of recurrent transient ischaemic attacks or stroke in men who have had transient ischaemia of the brain due to fibrin platelet emboli,
• to reduce the risk of graft occlusion following aorta coronary by-pass surgery.
dosage
Adults
For inhibition of platelet aggregation:
One to three tablets as directed by your doctor to be taken every day, preferably at the same time each day.
The optimal dose for inhibition of platelet aggregation in humans is not known. CANCARD should not be used for indications related to the inhibition of platelet aggregation unless directed by a doctor.
Paediatric population
CANCARD should not be administered to children and adolescents younger than 16 years.
how to take
For oral administration.
CANCARD should be swallowed whole. Do not chew, break or crush the tablet as this will destroy the protective effect of the enteric coating.
What CANCARD contains
Each enteric-coated tablet contains 81 mg aspirin (acetyl salicylic acid).
other ingredients
Sugar free
Colloidal anhydrous silica, hypromellose (E464), macrogol (E1521), methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30 % , microcrystalline cellulose, pregelatinised starch, purified talc, stearic acid, titanium dioxide (E171), triethyl citrate.
Therapeutic classification
B01AC06 (A 8 Medicines acting on the blood and haemopoietic system).